Rockwell Medical Inc (RMTI)
1.47
-0.05
(-3.29%)
USD |
NASDAQ |
Apr 24, 16:00
1.47
0.00 (0.00%)
After-Hours: 18:29
Rockwell Medical Total Liabilities (Quarterly): 30.88M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.88M |
| September 30, 2023 | 31.09M |
| June 30, 2023 | 28.51M |
| March 31, 2023 | 27.93M |
| December 31, 2022 | 32.53M |
| September 30, 2022 | 38.05M |
| June 30, 2022 | 38.97M |
| March 31, 2022 | 42.24M |
| December 31, 2021 | 46.04M |
| September 30, 2021 | 47.60M |
| June 30, 2021 | 45.48M |
| March 31, 2021 | 43.27M |
| December 31, 2020 | 43.58M |
| September 30, 2020 | 43.16M |
| June 30, 2020 | 42.37M |
| March 31, 2020 | 45.05M |
| December 31, 2019 | 24.00M |
| September 30, 2019 | 24.38M |
| June 30, 2019 | 27.48M |
| March 31, 2019 | 28.58M |
| December 31, 2018 | 25.28M |
| September 30, 2018 | 25.41M |
| June 30, 2018 | 24.53M |
| March 31, 2018 | 24.59M |
| December 31, 2017 | 25.87M |
| Date | Value |
|---|---|
| September 30, 2017 | 25.02M |
| June 30, 2017 | 25.63M |
| March 31, 2017 | 29.85M |
| December 31, 2016 | 30.20M |
| September 30, 2016 | 27.10M |
| June 30, 2016 | 29.51M |
| March 31, 2016 | 28.89M |
| December 31, 2015 | 25.50M |
| September 30, 2015 | 26.49M |
| June 30, 2015 | 25.54M |
| March 31, 2015 | 29.34M |
| December 31, 2014 | 29.30M |
| September 30, 2014 | 29.33M |
| June 30, 2014 | 29.80M |
| March 31, 2014 | 30.32M |
| December 31, 2013 | 35.77M |
| September 30, 2013 | 37.50M |
| June 30, 2013 | 36.79M |
| March 31, 2013 | 28.47M |
| December 31, 2012 | 26.99M |
| September 30, 2012 | 23.05M |
| June 30, 2012 | 17.42M |
| March 31, 2012 | 13.84M |
| December 31, 2011 | 13.69M |
| September 30, 2011 | 9.628M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
24.00M
Minimum
Dec 2019
47.60M
Maximum
Sep 2021
36.98M
Average
38.97M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.198M |
| Oragenics Inc | 1.798M |
| Alpine Immune Sciences Inc | 51.91M |
| Corvus Pharmaceuticals Inc | 6.869M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 52.17M |
| Shareholders Equity (Quarterly) | 21.29M |
| Debt to Equity Ratio | 0.401 |
| Current Ratio | 1.729 |
| Net Debt Paydown Yield | 2.38% |